Published in Biochem Biophys Res Commun on December 06, 1976
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76
Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst (1972) 4.06
A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst (1980) 3.75
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. J Natl Cancer Inst (1967) 2.50
Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92
Correlation of bacteria lipid composition with antibiotic resistance. J Bacteriol (1970) 1.82
Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. J Natl Cancer Inst (1973) 1.64
Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes. Toxicol Appl Pharmacol (1998) 1.59
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin. Int J Radiat Oncol Biol Phys (1979) 1.49
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis (2007) 1.48
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Carcinogenesis (2001) 1.44
Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein. Toxicol Sci (2001) 1.39
Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39
Clinical trials with exogenous interferon: summary of a meeting. J Infect Dis (1979) 1.36
In vitro and in vivo labelling of animal tumours with tritiated thymidine. Cell Tissue Kinet (1973) 1.36
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology (1972) 1.35
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33
The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop. Cancer Res (1985) 1.33
Oxygenation status of a transplantable tumor during fractionated radiation therapy. J Natl Cancer Inst (1968) 1.27
Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation. Cancer Res (1974) 1.27
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res (1973) 1.25
Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab (1970) 1.11
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08
Tumor oxygenation and reoxygenation during radiation therapy: their importance in predicting tumor response. Int J Radiat Oncol Biol Phys (1986) 1.07
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06
Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04
Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02
Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98
Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98
Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97
Hormone action at the membrane level. 3. Epinephrine interaction with the rat liver plasma membrane. Biochim Biophys Acta (1971) 0.95
Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133. Cancer Res (1972) 0.94
Interpolative background subtraction. J Nucl Med (1976) 0.94
Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. Carcinogenesis (2001) 0.91
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91
Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91
The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91
The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Int J Radiat Oncol Biol Phys (1985) 0.90
Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90
Hematologic toxicity of AZT and ddC administered as single agents and in combination to rats and mice. Fundam Appl Toxicol (1991) 0.89
Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89
HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89
Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88
Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88
Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumor. Int J Radiat Oncol Biol Phys (1994) 0.88
Biochemical responses of rat and mouse lung to inhaled nickel compounds. Toxicology (1989) 0.88
Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
Migration and internalization of cells and polystyrene microsphere in tumor cell spheroids. Exp Cell Res (1982) 0.87
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
From the National Institute of Allergy and Infectious Diseases. Update on clinical trials with exogenous interferon. J Infect Dis (1980) 0.86
Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85
Interferon, an antiviral drug for use in man. Tex Rep Biol Med (1977) 0.85
Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85
Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85
Kidney and urinary bladder lesions in F344/N rats and B6C3F1 mice after 13 weeks of 2,2-bis(bromomethyl)-1,3-propanediol administration. Fundam Appl Toxicol (1989) 0.84
Quantitative estimation of histological changes in subcutaneous vasculature of the mouse after x-irradiation. Int J Radiat Oncol Biol Phys (1977) 0.84
The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84
Growth and cell population kinetics of single and multiple KHT sarcomas. Cell Tissue Kinet (1972) 0.83
Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83
Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol (2003) 0.83
Comparative inhalation toxicity of nickel subsulfide to F344/N rats and B6C3F1 mice exposed for 12 days. Fundam Appl Toxicol (1987) 0.83
The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83
Bromodichloromethane, a trihalomethane that produces neoplasms in rodents. Cancer Res (1987) 0.83
Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82
Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol (1986) 0.82
Carcinogenesis bioassay of allyl isothiocyanate. Fundam Appl Toxicol (1983) 0.81
Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81
Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. VI. BCNU. Int J Radiat Oncol Biol Phys (1979) 0.81
Preferential radiosensitization of mouse sarcoma relative to normal skin by chronic intra-arterial infusion of halogenated pyrimidine analogs. J Natl Cancer Inst (1971) 0.80
Acute and chronic effects of x irradiation on blood flow in the mouse limb. Radiology (1974) 0.80
Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80
Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80
Reoxygenation in the RIF-1 tumor. Int J Radiat Oncol Biol Phys (1984) 0.79
Developmental toxicity of orally administered 2',3'-dideoxycytidine in mice. Teratology (1990) 0.79
Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79
Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79
Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79
Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration. Hum Mutat (2009) 0.79
In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79
Measurement of micronucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene. Environ Mol Mutagen (1998) 0.79
Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methylisopsoralen with ultraviolet radiation in the hairless (HRA/Skh) mouse. Toxicol Appl Pharmacol (1987) 0.79
Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor. Int J Radiat Oncol Biol Phys (1993) 0.78
A system for large-scale inbred mouse production, and a computer method to aid in subline selection. Lab Anim Care (1966) 0.78
The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide. Int J Radiat Oncol Biol Phys (1979) 0.78